MARINUS PHARMACEUTICALS, INC.

Profile

Company Names

MARINUS PHARMACEUTICALS, INC.
MARINUS PHARMACEUTICALS INC

Addresses

5 RADNOR CORPORATE CENTER, SUITE 500, 100 MATSONFORD ROAD, RADNOR, PA 19080

142 TEMPLE STREET, SUITE 205, NEW HAVEN, CT 06510

21 BUSINESS PARK DRIVE, BRANFORD, CT 06405

Phone Numbers

484-801-4670
203-315-0566

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$73,414,492.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-03-29 
$1,230,085.00 
$1,230,085.00 
$0.00 
Equity 
3
2019-12-11 
$30,000,000.00 
$30,000,000.00 
$0.00 
Equity 
2
2012-12-04 
$21,772,848.00 
$22,272,848.00 
$500,000.00 
Equity 
1
2009-04-08 
$20,411,559.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SANTIAGO 
 
ARROYO, M.D., PH.D. 
DIRECTOR
MARINUS PHARMACEUTICALS, INC.
CHARLES 
 
AUSTIN 
DIRECTOR
LONG HARBOUR EXPLORATION CORP.   |  MARINUS PHARMACEUTICALS, INC.
ALAN 
 
BARBER 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC   |  KARYOPHARM THERAPEUTICS INC.   |  ARCH THERAPEUTICS, INC.
STEPHEN 
 
BLOCH 
DIRECTOR
VIACOR INC   |  MARINUS PHARMACEUTICALS INC   |  LIQUIDIA TECHNOLOGIES INC   |  DICOM GRID INC   |  AXIAL EXCHANGE, INC.   |  ENVISIA THERAPEUTICS INC.   |  LQ3 PHARMACEUTICALS, INC.   |  ENVISIA THERAPEUTICS, INC.   |  SAMPLE6, INC.   |  GENOME MEDICAL HOLDING CO   |  CORVIUM, INC.   |  ONKOS SURGICAL, INC.   |  EVOLVEIMMUNE THERAPEUTICS HOLDING COMPANY, LLC   |  IANTREK, INC.   |  LIQUIDIA CORP   |  ALLYX THERAPEUTICS, INC.   |  THYRON PHARMACEUTICALS, INC.
STEPHEN 
 
BLOCH, M.D. 
DIRECTOR
MARINUS PHARMACEUTICALS INC
SCOTT 
 
BRAUNSTEIN, M.D. 
EXECUTIVE OFFICER, DIRECTOR
MARINUS PHARMACEUTICALS, INC.
SCOTT 
 
BRAUNSTEIN, MD 
EXECUTIVE OFFICER, DIRECTOR
MARINUS PHARMACEUTICALS INC
ENRIQUE 
J. 
CARRAZANA, MD 
DIRECTOR
MARINUS PHARMACEUTICALS INC
CHRISTOPHER 
M. 
CASHMAN 
EXECUTIVE OFFICER, DIRECTOR
MBF THERAPEUTICS, INC.   |  SANUWAVE, INC.   |  SANUWAVE HEALTH, INC.   |  JDP THERAPEUTICS, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  MARINUS PHARMACEUTICALS INC
MICHAEL 
R. 
DOUGHERTY 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  MARINUS PHARMACEUTICALS, INC.
ELAN 
 
EZICKSON 
DIRECTOR
AVEO PHARMACEUTICALS INC   |  MARINUS PHARMACEUTICALS INC   |  ASYLIA THERAPEUTICS, INC.   |  MARINUS PHARMACEUTICALS, INC.   |  CARMINE THERAPEUTICS, INC.
SETH 
H.Z. 
FISCHER 
DIRECTOR
AGILE THERAPEUTICS INC   |  MARINUS PHARMACEUTICALS INC   |  MARINUS PHARMACEUTICALS, INC.
ANTON 
 
GOPKA 
DIRECTOR
CODA THERAPEUTICS INC   |  MARINUS PHARMACEUTICALS INC   |  REGADO BIOSCIENCES INC
JOSEPH 
 
HULIHAN, M.D. 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS, INC.
JOE 
 
HULIHAN, MD 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC
JOHN 
 
KRAYACICH 
EXECUTIVE OFFICER, DIRECTOR
MARINUS PHARMACEUTICALS INC
MARTHA 
 
MANNING, ESQ. 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS, INC.
TIM 
M. 
MAYLEBEN 
DIRECTOR
ESPERION THERAPEUTICS, INC.   |  MARINUS PHARMACEUTICALS INC   |  MARINUS PHARMACEUTICALS, INC.
TIMOTHY 
 
MAYLEBEN 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  LYCERA CORP   |  DENOVO SCIENCES, INC.
TIMOTHY 
M. 
MAYLEBEN 
DIRECTOR
ESPERION THERAPEUTICS, INC.   |  AASTROM BIOSCIENCES INC   |  MARINUS PHARMACEUTICALS INC
ANAND 
 
MEHRA 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  VICEPT THERAPEUTICS, INC.   |  AERIE PHARMACEUTICALS INC   |  NEXTWAVE PHARMACEUTICALS INC   |  SPARK THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  FIRST AID BEVERAGES, INC.   |  SOFINNOVA VENTURE PARTNERS X, L.P.   |  MERUS N.V.   |  AMPLYX PHARMACEUTICALS, INC.
ANAND 
 
MEHRA, M.D. 
DIRECTOR
MARINUS PHARMACEUTICALS INC
SARASWATHY 
 
NOCHUR, PH.D. 
DIRECTOR
MARINUS PHARMACEUTICALS, INC.
HARRY 
 
PENNER 
DIRECTOR
MARINUS PHARMACEUTICALS INC
HARRY 
H. 
PENNER, JR. 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.
STEVEN 
E. 
PFANSTIEL 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS, INC.   |  LUNGPACER MEDICAL, INC.
HARRY 
T. 
REIN 
DIRECTOR
ILLUMINOSS MEDICAL INC   |  MARINUS PHARMACEUTICALS INC
KENNETH 
 
SHAW 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC
EDWARD 
F. 
SMITH 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC
CABLE 
 
STUART 
EXECUTIVE OFFICER
MARINUS PHARMACEUTICALS INC
NICOLE 
 
VITULLO 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  VENTIRX PHARMACEUTICALS INC   |  ESPERION THERAPEUTICS, INC.   |  CELATOR PHARMACEUTICALS INC   |  ABREXA PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  DOMAIN PARTNERS IX, L.P.   |  CELTAXSYS, INC.   |  COTERA, INC.   |  EXALYS THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  MARINUS PHARMACEUTICALS, INC.   |  ALLAY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-04
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-29 
2019-12-19
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-12-11 
2013-07-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-04 
2012-12-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-04 
2009-04-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
N/A
NONE
OPPENHEIMER + CO., INC
249
N/A
NONE
LADENBURG THALMANN + CO. INC.
505
N/A
NONE
CRAIG-HALLUM CAPITAL GROUP LLC
121395